1. Home
  2. FAMI vs SNSE Comparison

FAMI vs SNSE Comparison

Compare FAMI & SNSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Farmmi Inc.

FAMI

Farmmi Inc.

HOLD

Current Price

$1.48

Market Cap

8.7M

ML Signal

HOLD

Logo Sensei Biotherapeutics Inc.

SNSE

Sensei Biotherapeutics Inc.

HOLD

Current Price

$8.40

Market Cap

10.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FAMI
SNSE
Founded
2015
2005
Country
China
United States
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.7M
10.3M
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
FAMI
SNSE
Price
$1.48
$8.40
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$72.50
AVG Volume (30 Days)
5.8K
86.0K
Earning Date
01-26-2026
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$43,831,754.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.26
$5.00
52 Week High
$7.07
$18.35

Technical Indicators

Market Signals
Indicator
FAMI
SNSE
Relative Strength Index (RSI) 44.81 47.09
Support Level $1.45 $7.45
Resistance Level $1.54 $13.26
Average True Range (ATR) 0.10 1.19
MACD 0.01 0.01
Stochastic Oscillator 65.09 18.93

Price Performance

Historical Comparison
FAMI
SNSE

About FAMI Farmmi Inc.

Farmmi Inc is an investment holding company. Through its subsidiaries, it acts as a supplier of agricultural products. It is an agricultural technology enterprise focused on its supply chain platform by promoting edible mushroom products and agriculture technology. Its product offerings include tapioca, corn, red dates, shiitake mushrooms, mu er fungus, other edible fungi, and other agricultural products. Geographically, the company's products are sold in China, Southeast Asia, Japan, North America, Europe, and the Middle East under the Forasen and Farmmi brands.

About SNSE Sensei Biotherapeutics Inc.

Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).

Share on Social Networks: